Valuation: Amarin Corporation plc

Market Cap 343M 301M 277M 259M 487M 32.35B 496M 3.33B 1.29B 15.95B 1.29B 1.26B 55.42B P/E 2026 *
-467x
P/E 2027 * 297x
Enterprise Value 169M 148M 137M 128M 240M 15.94B 244M 1.64B 636M 7.86B 635M 621M 27.31B EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.81x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day-0.37%
1 week+2.00%
Current month+12.84%
1 month+13.31%
3 months+11.38%
6 months+19.34%
Current year+17.16%
1 week 15.16
Extreme 15.16
17.25
1 month 13.6
Extreme 13.6
17.25
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
29.7
5 years 7.08
Extreme 7.08
119.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap.
04-18Fiscal year

Director

2,079 0.0005%
04-18Fiscal year

Director

2,079 0.0005%
04-18Fiscal year

Chairman

2,079 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%+2.00%+0.99%-28.29% 343M
+0.33%+1.50%+64.24%+119.39% 55.35B
+1.58%+14.12%+72.87%+85.18% 51.92B
-0.37%-0.98%-14.12%-16.00% 22.76B
+1.23%+9.05%-0.36%+423.40% 22.64B
-0.18%+7.48%+32.16%-14.07% 17.36B
-3.66%+1.56%+25.67%-36.05% 16.1B
+3.02%+12.74%+143.33%+308.04% 13.96B
+0.77%+2.54%+22.28%+168.03% 13.38B
+1.31%+6.52%+28.62% - 12.27B
Average +0.33%+5.44%+37.57%+112.18% 22.61B
Weighted average by Cap. +0.54%+6.54%+47.02%+121.45%

Financials

2026 *2027 *
Net sales 182M 160M 147M 138M 259M 17.2B 263M 1.77B 685M 8.48B 684M 669M 29.46B 193M 169M 156M 146M 274M 18.2B 279M 1.87B 726M 8.97B 724M 709M 31.18B
Net income -15.02M -13.2M -12.16M -11.37M -21.32M -1.42B -21.71M -146M -56.5M -699M -56.42M -55.18M -2.43B 22.13M 19.44M 17.91M 16.75M 31.41M 2.09B 31.99M 215M 83.24M 1.03B 83.11M 81.29M 3.58B
Net Debt -174M -153M -141M -132M -247M -16.41B -251M -1.69B -654M -8.09B -653M -639M -28.1B -187M -165M -152M -142M -266M -17.69B -271M -1.82B -705M -8.72B -704M -689M -30.31B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
25/06/26 US$16.35 -0.37% 84,412
24/06/26 US$16.41 +2.76% 125,513
23/06/26 US$15.97 +1.01% 124,817
22/06/26 US$15.81 -1.37% 166,093
18/06/26 US$16.03 +1.65% 87,091
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
16.35USD
Average target price
12.50USD
Spread / Average Target
-23.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock